Global Castrate Resistant Prostate Cancer Therapeutics Competitive Landscape Professional Research Report 2024

Research Summary

Castrate-resistant prostate cancer (CRPC) therapeutics refer to treatments and therapies used to manage and combat prostate cancer that has progressed despite the suppression of testosterone levels, also known as castration. CRPC occurs when prostate cancer cells adapt and continue to grow despite the absence of testosterone, which is typically responsible for fueling their growth. The therapeutics for CRPC aim to target alternative pathways and mechanisms that allow the cancer cells to thrive and survive in the absence of testosterone. These therapies include hormone-based treatments, such as androgen receptor-targeted agents, as well as chemotherapy, immunotherapy, targeted molecular therapies, and radiopharmaceuticals. The goal of castrate-resistant prostate cancer therapeutics is to slow disease progression, manage symptoms, and potentially extend survival for patients with this advanced stage of prostate cancer.

According to DIResearch's in-depth investigation and research, the global Castrate Resistant Prostate Cancer Therapeutics market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Castrate Resistant Prostate Cancer Therapeutics include Pfizer/Astellas (Xtandi), Johnson & Johnson, AstraZeneca/Merck (Lynparza), Bayer, Jiangsu Hengrui Pharmaceuticals, CTTQ, Sanofi, Zhendong Pharmaceutical, Hansoh, Clovis Oncology etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Castrate Resistant Prostate Cancer Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Castrate Resistant Prostate Cancer Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Castrate Resistant Prostate Cancer Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Castrate Resistant Prostate Cancer Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Castrate Resistant Prostate Cancer Therapeutics Include:

Pfizer/Astellas (Xtandi)

Johnson & Johnson

AstraZeneca/Merck (Lynparza)

Bayer

Jiangsu Hengrui Pharmaceuticals

CTTQ

Sanofi

Zhendong Pharmaceutical

Hansoh

Clovis Oncology

Castrate Resistant Prostate Cancer Therapeutics Product Segment Include:

Hormonal Therapy

Chemotherapy

Others

Castrate Resistant Prostate Cancer Therapeutics Product Application Include:

Hospital

Specialty Clinic

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Castrate Resistant Prostate Cancer Therapeutics Industry PESTEL Analysis

Chapter 3: Global Castrate Resistant Prostate Cancer Therapeutics Industry Porter's Five Forces Analysis

Chapter 4: Global Castrate Resistant Prostate Cancer Therapeutics Major Regional Market Size and Forecast Analysis

Chapter 5: Global Castrate Resistant Prostate Cancer Therapeutics Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Castrate Resistant Prostate Cancer Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Castrate Resistant Prostate Cancer Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Castrate Resistant Prostate Cancer Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Castrate Resistant Prostate Cancer Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Castrate Resistant Prostate Cancer Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Castrate Resistant Prostate Cancer Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Castrate Resistant Prostate Cancer Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Castrate Resistant Prostate Cancer Therapeutics Market Overview

1.1 Product Definition and Statistical Scope

1.2 Castrate Resistant Prostate Cancer Therapeutics Product by Type

1.2.1 Global Castrate Resistant Prostate Cancer Therapeutics Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Hormonal Therapy

1.2.3 Chemotherapy

1.2.4 Others

1.3 Castrate Resistant Prostate Cancer Therapeutics Product by Application

1.3.1 Global Castrate Resistant Prostate Cancer Therapeutics Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Hospital

1.3.3 Specialty Clinic

1.3.4 Others

1.4 Global Castrate Resistant Prostate Cancer Therapeutics Market Revenue Analysis (2019-2030)

1.5 Castrate Resistant Prostate Cancer Therapeutics Market Development Status and Trends

1.5.1 Castrate Resistant Prostate Cancer Therapeutics Industry Development Status Analysis

1.5.2 Castrate Resistant Prostate Cancer Therapeutics Industry Development Trends Analysis

2 Castrate Resistant Prostate Cancer Therapeutics Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Castrate Resistant Prostate Cancer Therapeutics Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Castrate Resistant Prostate Cancer Therapeutics Market Analysis by Regions

4.1 Castrate Resistant Prostate Cancer Therapeutics Overall Market: 2023 VS 2024 VS 2030

4.2 Global Castrate Resistant Prostate Cancer Therapeutics Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Castrate Resistant Prostate Cancer Therapeutics Revenue and Market Share by Region (2019-2024)

4.2.2 Global Castrate Resistant Prostate Cancer Therapeutics Revenue Forecast by Region (2025-2030)

5 Global Castrate Resistant Prostate Cancer Therapeutics Market Size by Type and Application

5.1 Global Castrate Resistant Prostate Cancer Therapeutics Market Size by Type

5.2 Global Castrate Resistant Prostate Cancer Therapeutics Market Size by Application

6 North America

6.1 North America Castrate Resistant Prostate Cancer Therapeutics Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Castrate Resistant Prostate Cancer Therapeutics Market Size by Type

6.4 North America Castrate Resistant Prostate Cancer Therapeutics Market Size by Application

6.5 North America Castrate Resistant Prostate Cancer Therapeutics Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Castrate Resistant Prostate Cancer Therapeutics Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Castrate Resistant Prostate Cancer Therapeutics Market Size by Type

7.4 Europe Castrate Resistant Prostate Cancer Therapeutics Market Size by Application

7.5 Europe Castrate Resistant Prostate Cancer Therapeutics Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Castrate Resistant Prostate Cancer Therapeutics Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Castrate Resistant Prostate Cancer Therapeutics Market Size by Type

8.4 China Castrate Resistant Prostate Cancer Therapeutics Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Castrate Resistant Prostate Cancer Therapeutics Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Castrate Resistant Prostate Cancer Therapeutics Market Size by Type

9.4 APAC (excl. China) Castrate Resistant Prostate Cancer Therapeutics Market Size by Application

9.5 APAC (excl. China) Castrate Resistant Prostate Cancer Therapeutics Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Castrate Resistant Prostate Cancer Therapeutics Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Castrate Resistant Prostate Cancer Therapeutics Market Size by Type

10.4 Latin America Castrate Resistant Prostate Cancer Therapeutics Market Size by Application

10.5 Latin America Castrate Resistant Prostate Cancer Therapeutics Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Castrate Resistant Prostate Cancer Therapeutics Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Castrate Resistant Prostate Cancer Therapeutics Market Size by Type

11.4 Middle East & Africa Castrate Resistant Prostate Cancer Therapeutics Market Size by Application

11.5 Middle East & Africa Castrate Resistant Prostate Cancer Therapeutics Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Castrate Resistant Prostate Cancer Therapeutics Market Revenue by Key Manufacturers (2020-2024)

12.2 Castrate Resistant Prostate Cancer Therapeutics Competitive Landscape Analysis and Market Dynamic

12.2.1 Castrate Resistant Prostate Cancer Therapeutics Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Pfizer/Astellas (Xtandi)

13.1.1 Pfizer/Astellas (Xtandi) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Pfizer/Astellas (Xtandi) Castrate Resistant Prostate Cancer Therapeutics Product Portfolio

13.1.3 Pfizer/Astellas (Xtandi) Castrate Resistant Prostate Cancer Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Johnson & Johnson

13.2.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Johnson & Johnson Castrate Resistant Prostate Cancer Therapeutics Product Portfolio

13.2.3 Johnson & Johnson Castrate Resistant Prostate Cancer Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 AstraZeneca/Merck (Lynparza)

13.3.1 AstraZeneca/Merck (Lynparza) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 AstraZeneca/Merck (Lynparza) Castrate Resistant Prostate Cancer Therapeutics Product Portfolio

13.3.3 AstraZeneca/Merck (Lynparza) Castrate Resistant Prostate Cancer Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Bayer

13.4.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Bayer Castrate Resistant Prostate Cancer Therapeutics Product Portfolio

13.4.3 Bayer Castrate Resistant Prostate Cancer Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Jiangsu Hengrui Pharmaceuticals

13.5.1 Jiangsu Hengrui Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Jiangsu Hengrui Pharmaceuticals Castrate Resistant Prostate Cancer Therapeutics Product Portfolio

13.5.3 Jiangsu Hengrui Pharmaceuticals Castrate Resistant Prostate Cancer Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 CTTQ

13.6.1 CTTQ Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 CTTQ Castrate Resistant Prostate Cancer Therapeutics Product Portfolio

13.6.3 CTTQ Castrate Resistant Prostate Cancer Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Sanofi

13.7.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Sanofi Castrate Resistant Prostate Cancer Therapeutics Product Portfolio

13.7.3 Sanofi Castrate Resistant Prostate Cancer Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Zhendong Pharmaceutical

13.8.1 Zhendong Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Zhendong Pharmaceutical Castrate Resistant Prostate Cancer Therapeutics Product Portfolio

13.8.3 Zhendong Pharmaceutical Castrate Resistant Prostate Cancer Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Hansoh

13.9.1 Hansoh Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Hansoh Castrate Resistant Prostate Cancer Therapeutics Product Portfolio

13.9.3 Hansoh Castrate Resistant Prostate Cancer Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Clovis Oncology

13.10.1 Clovis Oncology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Clovis Oncology Castrate Resistant Prostate Cancer Therapeutics Product Portfolio

13.10.3 Clovis Oncology Castrate Resistant Prostate Cancer Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Castrate Resistant Prostate Cancer Therapeutics Industry Chain Analysis

14.2 Castrate Resistant Prostate Cancer Therapeutics Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Castrate Resistant Prostate Cancer Therapeutics Typical Downstream Customers

14.4 Castrate Resistant Prostate Cancer Therapeutics Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support